1,739
Participants
Start Date
August 31, 2006
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
Interferon beta-1b (Betaseron, BAY86-5046)
Intravenous therapy according to product information
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Many Locations
Lead Sponsor
Bayer
INDUSTRY